Identification of interaction partners of outer inflammatory protein A: Computational and experimental insights into

Sümeyye Akcelik-Deveci1, Elif Kılıç1, Nesteren Mansur-Ozen1

  • 1Department of Medical Biotechnology, Institute of Health Sciences, Acibadem University, Atasehir, Istanbul, Turkey.

Plos One
|October 29, 2024
PubMed

Insights

Outer inflammatory protein A (OipA) from Helicobacter pylori interacts with host cells. This study identifies novel human protein partners, including HGF, Met, and AGRB1, crucial for bacterial adherence and potential therapeutic targets.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Cell Biology

Background:

  • Outer membrane proteins (OMPs) are vital for Helicobacter pylori survival in gastric tissue.
  • Outer inflammatory protein A (OipA) is essential for H. pylori adherence to gastric epithelial cells.
  • The structural mechanisms of OipA's adherence function are not fully understood.

Purpose of the Study:

  • To investigate the interaction partners of OipA on the gastric epithelial cell surface.
  • To elucidate the structural mechanisms of OipA-mediated adherence.
  • To identify potential therapeutic targets for H. pylori infection.

Main Methods:

  • Proteomic analysis using pull-down assays with recombinant OipA.
  • Identification of the OipA interactome from gastric epithelial cell membrane proteins.
  • Molecular modeling of OipA-host protein interactions.

Main Results:

  • Proteomic analysis identified 704 unique OipA interacting proteins.
  • Molecular modeling analyzed 16 OipA partners.
  • Three key human proteins—HGF, Met, and AGRB1—were highlighted for their role in OipA-mediated adherence.

Conclusions:

  • OipA engages in novel interactions with host proteins on the gastric epithelial cell surface.
  • HGF, Met, and AGRB1 are identified as potential mediators of H. pylori adherence.
  • These identified host interactions represent potential therapeutic targets for H. pylori infections.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
542
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
91
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
139
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
262